Kelly Services (KELYA) Q4 2025 earnings review
Stabilization Remains Elusive as Profits Halve
Kelly Services ended FY25 with a difficult quarter, reporting an 11.9% YoY revenue decline and a 51.7% drop in Adjusted EBITDA. While the Education segment provided a faint bright spot (+1.3% growth), the core Staffing and SET segments contracted sharply due to 'discrete impacts' from federal government demand reduction and customer losses. The bottom line was decimated by a $127.9M valuation allowance on tax assets, resulting in a GAAP loss of $128.8M. Guidance for Q1 2026 promises more of the same pain (Revenue down ~12%, EBITDA margin compressing to ~1.5%) before a promised—but yet to be proven—recovery in H2.
🐂 Bull Case
In a sea of red, Education remains a stronghold, growing 1.3% YoY in Q4 and 3.9% for the full year. As a counter-cyclical asset with 90%+ fill rates, this segment provides a floor for performance.
Adjusted SG&A expenses fell 11.1% YoY, outpacing the underlying revenue decline. Management is aggressively cutting structural costs and consolidating technology stacks, which could create significant operating leverage if volumes eventually return.
🐻 Bear Case
Adjusted EBITDA margin collapsed to 2.0% (down 170bps YoY) and is guided even lower to 1.5% for Q1 26. The 52% drop in EBITDA on an 12% revenue drop demonstrates severe negative operating leverage.
The company recorded a massive $127.9M valuation allowance against deferred tax assets (tax credits). This is a major red flag: accounting rules require this when it is 'more likely than not' that the company won't generate enough future taxable income to use them.
⚖️ Verdict: 🔴🔴
Bearish. The 'stabilization' narrative is contradicted by Q1 2026 guidance, which calls for continued revenue double-digit declines and further margin compression. The massive tax asset writedown suggests management (or at least their auditors) sees low near-term profitability.
Key Themes
Discrete Impacts Dragging Down Top Line
Management continues to cite 'discrete impacts' (reduced U.S. federal government demand + loss of three large commercial customers) as the primary anchor, accounting for ~8% of the revenue decline. This narrative has persisted for three quarters. Q4 revenue fell 11.9% reported; even excluding these impacts, underlying revenue fell 3.9%, indicating weakness extends beyond these specific clients.
Margin Compression Accelerating
Adjusted EBITDA margin fell 170 basis points to 2.0%. Management attributes this to 'near-term gross margin pressure' in SET and ETM due to employee-related costs and business mix. Worryingly, the outlook for Q1 26 is even worse (1.5%), suggesting the bottom is not yet in.
Cost Optimization & Modernization
A key positive is the 11.1% reduction in adjusted SG&A. The company completed the first phase of its technology modernization (consolidating SET acquisitions onto a unified platform). This structural cleanup is vital, but currently insufficient to offset the gross profit dollars lost from falling revenue.
Tax Valuation Allowance Shock
GAAP Net Income was wiped out by a $126.2M tax expense, primarily due to a $127.9M valuation allowance. This accounting charge implies that cumulative losses have been significant enough that the company can no longer book the value of its tax credit carryforwards as an asset. It reflects poor historical profitability and limited visibility into near-term taxable income.
SET Segment Reversal
The Science, Engineering & Technology (SET) segment, previously a growth engine aided by acquisitions like MRP, has turned negative. Revenue fell 11.3% YoY (organic and inorganic mix). Gross profit dollars in this high-margin segment fell 16.2%, disproportionately hurting the bottom line.
Other KPIs
Decelerating. Down significantly from $0.79 in 24Q4 and $0.18 in 25Q3. The decline reflects the flow-through of lower sales and compressed margins, partially cushioned by a lower share count.
Accelerating. A bright spot in the report, up sixfold from $15.8M in FY24. This was driven by working capital management (accounts receivable collections) amidst declining revenue, rather than earnings growth. Liquidity remains adequate with $158M in capital deployed for buybacks/dividends/debt repayment.
Decelerating. Down 150 basis points from 20.3% a year ago. Pressure stemmed from increased employee-related costs and a negative mix shift (growth in lower-margin Education vs declines in higher-margin SET/Outcome-based services).
Guidance
Stable (Negative). The guidance implies the revenue trough has not yet passed and is roughly consistent with the -11.9% seen in Q4. Underlying revenue (ex-discrete items) is expected to be down 3-5%.
Decelerating. This is below the 2.0% realized in 25Q4 and significantly below the 3.0% seen in 25Q1. Includes impact of annual payroll tax resets, but signals continued profitability pressure.
Accelerating (Projected). Management expects a return to organic growth and margin expansion in H2 26. Given the weak Q1 start, this implies a steep ramp in performance is required in the back half of the year.
Key Questions
H2 Recovery Visibility
Management guides for a 'return to organic growth' in H2 2026 despite guiding Q1 down ~12%. What specific leading indicators or contract wins support such a sharp pivot in trajectory mid-year?
Valuation Allowance Implications
The $127.9M valuation allowance suggests uncertainty regarding future taxable income. Does this impact the company's ability to maintain the dividend or share repurchase pace if GAAP losses persist?
Gross Margin Stabilization
With Gross Profit rate down 150bps to 18.8%, and mix shifting toward Education (lower margin), when does management expect the gross margin compression to bottom out?
SET Segment Health
SET revenue dropped 11.3% despite the integration of MRP. Is this purely macro-driven, or are there execution issues with the integration of the acquired platforms?